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Summary
Background: Rapid and accurate methods for screening are necessary for the diag-
nosis of acute cardiovascular diseases (ACVD), including acute coronary syndrome
(ACS), pulmonary thromboembolism, and acute aortic dissection. In this study, the
utility of rapid D-dimer measurement for the screening of ACVD was evaluated.
Methods and results: Consecutive 279 emergent patients in whom ACVD was sus-
pected or not ruled out were enrolled. The median D-dimer concentration of
ACVD group (1.10g/ml) was signiﬁcantly higher than that in the non-ACVD group
(0.69g/ml, p < 0.05). Sensitivity, speciﬁcity, positive predictive value, and negative
predictive value of D-dimer (with cut-off level of 0.75g/ml) for the discrimination
of ACVD from non-ACVD was 75%, 55%, 38%, and 85%, respectively. In ACVD group,
the level of D-dimer in the large vessel disease subgroup was signiﬁcantly higher
than that in the ACS subgroup (6.99g/ml and 0.89g/ml, respectively; p < 0.05).
The well-balanced cut-off point for discriminating the two subgroups was D-dimer
level of 5.0g/ml. D-dimer (with cut-off level of 0.75g/ml) showed signiﬁcantly
higher positive test rate for the detection of ACS in very early phase (within 2 h from
the onset) compared with troponin T (p < 0.05).
Conclusions: Rapid measurement of D-dimer is useful for the screening of ACVD in
the emergency setting.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
reserved.
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ntroduction
cute cardiovascular diseases (ACVD), such as acute
oronary syndrome (ACS), pulmonary thromboem-
olism, and acute aortic dissection are sometimes
atal and are difﬁcult to diagnose promptly. There-
ore, rapid and accurate methods for screening are
esirable. Previous studies showed the utility of
-dimer measurement in serum for the diagnosis
f pulmonary thromboembolism and acute aortic
issection [1—6]. However, the utility of D-dimer
easurement for the diagnosis of acute coronary
yndrome was controversial in previous studies
7—10]. There are few reports using rapid mea-
urement of D-dimer for the screening of ACVD in
he outpatient clinic for emergent patients. There-
ore, in this prospective study, we examined the
tility of rapid D-dimer measurement in serum for
he screening of ACVD in the emergency setting.
e also investigated the utility of rapid D-dimer
easurement for the diagnosis of ACS.
ethods
ubjects
he study group included consecutively enrolled
79 emergent patients [169 men and 110 women,
edian age 62 (range 53—75) years] in whom ACVD
as suspected or not ruled out, who presented in
he emergency setting from June 2004 to Septem-
er 2006. Chief complaints of these patients were
hest pain (62%), dyspnea (17%), back pain (9%),
alpitation (7%), and other symptoms (5%). Rapid
-dimer measurement in serum, general laboratory
valuation, electrocardiography, and chest radio-
raphy were performed in all cases. In addition,
hest computed tomography (CT) and/or echocar-
iography were performed when needed. Acute
ortic dissection, impending rupture of thoracic
r abdominal aneurysm, and pulmonary throm-
oembolism were diagnosed by enhanced CT. Acute
ortic dissection was diagnosed on the basis of CT
ndings of false lumen and/or intimal ﬂap, and
ulmonary thromboembolism was diagnosed on the
asis of CT ﬁndings of a thrombus in pulmonary
rtery [3,11]. ACS was diagnosed by electrocardiog-
aphy, echocardiography, and biochemical markers,
ncluding troponin T, creatine kinase (CK), and cre-
tine kinase MB isozyme (CKMB). We deﬁned acute
yocardial infarction as a typical increase of bio-
hemical markers, especially troponin T, with at
east one of the following: typical chest pain, ST-
egment elevation or depression of at least 1mm in
d
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wo or more contiguous leads [12]. Unstable angina
as deﬁned as ischemic chest pain at rest that
asted at least 15min, new-onset angina, or accel-
rating angina [13]. Patients who were considered
egative for ACVD were followed and underwent
ther examinations for the ﬁnal diagnosis. This
tudy was approved by the institutional ethics com-
ittee and informed consent was obtained from all
atients.
lassiﬁcation of patients
atients were classiﬁed into ACVD group and
on-ACVD group according to the ﬁnal diagnosis
Table 1). Then the ACVD group was divided into
subgroups (ACS subgroup and large vessel disease
ubgroup). Seventy-ﬁve patients were assigned to
he ACVD group and 204 patients were assigned
o the non-ACVD group. In the ACVD group, 60
atients were assigned to the ACS subgroup; these
ncluded 53 patients with acute myocardial infarc-
ion and 7 with unstable angina. Fifteen patients
ere assigned to large vessel disease subgroup
ncluding 3 patients with acute aortic dissection,
with impending rupture of thoracic or abdominal
neurysm, 5 with pulmonary thromboembolism, 1
ith acute occlusion of subclabian artery, 2 with
hrombophlebitis, and 1 with deep vein thrombo-
is. The non-ACVD group included 19 patients with
table angina, 13 with chronic heart failure, 12 with
rrhythmia, and 160 patients who were diagnosed
egative for any cardiovascular diseases.
apid D-dimer measurement
enous blood was drawn as soon as possible after
he patients came to the emergency room, and the
lood was centrifuged at 3000× g for 10min. Rapid
-dimer measurement in serum was performed by
he Nanopia® D-dimer assay (Daiichi Pure Chemicals
o., Tokyo, Japan), using the latex turbidimetric
mmnoassay method. This assay used anti-human D-
imer mouse monoclonal antibody. The assay takes
0min to perform.
-dimer measurement for diagnosis of acute
ardiovascular disease
he median values of D-dimer of each group were
ompared to evaluate the diagnostic accuracy of D-
imer for the discrimination of the ACVD group from
he non-ACVD group. Several cut-off levels of D-
imer that could discriminate the ACVD group from
on-ACVD group were examined. At ﬁrst, we eval-
ated a cut-off level of 0.5g/ml D-dimer that has
336 Y. Tokita et al.
Table 1 Classiﬁcation of patients.
Group Number of patients
ACVD group n = 75 66 (56, 75) years M/F 59/16
ACS subgroup n = 60 64 (55, 75) years M/F 52/8
Acute myocardial infarction 53
Unstable angina 7
Large vessel disease subgroup n = 15 75 (65, 84) years M/F 7/8
Acute aortic dissection 3
Impending rupture of aortic aneurysm 3
Pulmonary thromboembolism 5
Others 4
Non-ACVD group n = 204 61 (52, 72) years M/F 110/94
Stable angina 19
Heart failure 13
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group (Table 2). The values of D-dimer in the ACVD
group, the ACS subgroup, and the large vessel dis-
ease subgroup were signiﬁcantly higher than that in
the non-ACVD group (p < 0.05), respectively. In the
Table 2 The median values of D-dimer in the various
groups.
Group D-dimer (g/ml)
ACVD group 1.10 (0.73,2.16)*
ACS subgroup 0.89 (0.60, 1.67)*
Large vessel disease
subgroup
6.99 (5.59, 10.71)*,#
Non-ACVD group 0.69 (0.25, 1.14)Arrhythmia
Without cardiovascular disease
ACVD, acute cardiovascular disease; ACS, acute coronary synd
been reported previously by several investigations
for the diagnosis of pulmonary thromboembolism,
acute aortic dissection, and acute myocardial
infarction [3,4,6,9]. Then we evaluated other cut-
off levels of D-dimer provided by the receiver
operating characteristic (ROC) curve analysis. The
levels of D-dimer for the discrimination among the
ACS subgroup, large vessel disease subgroup, and
non-ACVD group were also evaluated.
D-dimer measurement for diagnosis of acute
coronary syndrome
We compared the diagnostic accuracy of D-dimer
levels with cardiac biochemical markers, includ-
ing troponin T and heart-type fatty acid-binding
protein (H-FABP) in the patients with ACS. The qual-
itative tests of each marker (troponin T: TROP T
sensitive®, Roche Diagnostics Co., Basel, Switzer-
land; H-FABP: Rapicheck®, Dainippon Sumitomo
Pharma Co., Osaka, Japan) were used. These
markers are highly selective for the detection of
myocardial injury, but both markers, especially tro-
ponin T, show low sensitivity in the superacute
phase, within a couple of hours after the onset of
ACS [14—16]. Therefore, we compared the diagnos-
tic accuracy of each marker according to the time
after the onset of ACS.
Statistical analysisAll continuous variables were expressed as median
values (25th percentile, 75th percentile). The
Kruskal—Wallis H-test was used to compare differ-
ences in variables between the groups. The value of
D-dimer concentration to discriminate the patients12
160
.
mong the groups was determined by ROC curve
nalysis. The Sigma Stat software (Ver 3.11, Systat
oftware Inc, Chicago, USA) and the SPSS II soft-
are (version 11.01, SPSS Inc., Chicago, USA) were
sed for all statistical analysis. A p-value of <0.05
as considered statistically signiﬁcant.
esults
omparison of the serum concentration of
-dimer among the groups
he median values of D-dimer in the various groups
ere: 1.10 (0.73, 2.16)g/ml in the ACVD group,
.89 (0.60, 1.67)g/ml in the ACS subgroup, 6.99
5.59, 10.71)g/ml in the large vessel disease sub-
roup, and 0.69 (0.25, 1.14)g/ml in the non-ACVDACVD, acute cardiovascular disease; ACS, acute coronary syn-
drome
* p < 0.05 vs. non-ACVD group.
# p < 0.05 vs. ACS subgroup
D-dimer measurement for screening of acute cardiovas
Figure 1 Receiver operating characteristic (ROC) curve
to discriminate the patients with ACVD from the non-
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higher positive rate in the patients with ACS inCVD group. The well-balanced cut-off point of D-dimer
as 0.75g/ml. AUC, area under the curve.
CVD group, the value of D-dimer in the large ves-
el disease subgroup was signiﬁcantly higher than
hat in the ACS subgroup (Table 2).
-dimer measurement for diagnosis of acute
ardiovascular disease
e attempted to determine the level of serum D-
imer that could discriminate the patients with
CVD from those in the non-ACVD group, using ROC
urve analysis. The well-balanced cut-off level of
-dimer was 0.75g/ml (Fig. 1).
Table 3 shows the diagnostic accuracy of D-dimer
easurement with various cut-off levels to discrim-
nate patients with ACVD from non-ACVD. When
he cut-off level of D-dimer was set at 0.5g/ml,
he sensitivity was 92% and the negative predictive
alue was 90%. When it was set at a well-balanced
evel of 0.75g/ml obtained from the ROC curve,
ensitivity was 75%, speciﬁcity was 55%, positive
redictive value was 38%, and negative predictive
alue was 85%. We also set another cut-off level of
-dimer at 5.0g/ml which showed a high speci-
city of 99% and a positive predictive value of 93%.
t
t
i
Table 3 Diagnostic accuracy of D-dimer level to discrimina
non-ACVD.
Cut-off D-dimer level (g/ml) Sensitivity (%)
>0.5 92
>0.75 75
>5.0 19
PPV, positive predictive value; NPV, negative predictive value.cular disease 337
Then, we tried to determine the level of D-
imer that could discriminate the patients among
he ACS subgroup, large vessel disease subgroup,
nd non-ACVD group. The well-balanced cut-off
evel of D-dimer to discriminate between the
CS subgroup and non-ACVD group was 0.75g/ml
Fig. 2A), between the large vessel disease sub-
roup and non-ACVD group was 5.0g/ml (Fig. 2B),
nd between the ACS subgroup and large vessel
isease subgroup was 5.0g/ml (Fig. 2C). With
he cut-off level of 0.75g/ml to discriminate
etween the ACS subgroup and non-ACVD group,
ensitivity was 68%, speciﬁcity was 56%, positive
redictive value was 31%, and negative predictive
alue was 86%. And with the cut-off level of
.0g/ml to discriminate between the large vessel
isease subgroup and non-ACVD group, sensitivity
as 87%, speciﬁcity was 99%, positive predic-
ive value was 93%, and negative predictive
alue was 99%. As to the discrimination between
he ACS subgroup and large vessel disease sub-
roup, the cut-off level of 5.0g/ml yielded the
ensitivity 87%, speciﬁcity 98%, positive predic-
ive value 93%, and negative predictive value
7%.
-dimer measurement for diagnosis of acute
oronary syndrome
able 4 shows the diagnostic accuracy of each
arker to discriminate patients with ACS from
hose in non-ACVD group. The average time
hen the level of D-dimer, troponin T and H-
ABP were determined from the onset of ACS
as 4 h and 40min. Fifty-ﬁve of 60 patients
ith acute coronary syndrome were enrolled in
he time course analysis, excluding 5 patients
n whom the time of onset of ACS was unde-
ermined. Table 5 shows the positive rate of
-dimer (≥0.75g/ml) and cardiac biochemical
arkers according to the time after the onset
f symptoms of ACS. D-dimer showed signiﬁcantlyhe very early phase (within 2 h) compared with
roponin T (p < 0.05). Although H-FABP showed pos-
tive rate of 47% within 2 h, it did not reach
te the patients with acute cardiovascular disease from
Speciﬁcity (%) PPV (%) NPV (%)
27 32 90
55 38 85
99 93 77
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Figure 2 Receiver operating characteristic (ROC) curve to discriminate the patients between ACS subgroup and non-
ACVD (A), between large vessel disease subgroup and non-ACVD group (B), and between ACS subgroup and large vessel
disease subgroup (C). AUC, area under the curve.
Table 4 Diagnostic accuracy of each Marker to discriminate patients with ACS from non-ACVD.
Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
D-dimer (≥0.75) 68 55 31 85
TropT 45 98 87 83
H-FABP 70 82 58 88
PPV, positive predictive value; NPV, negative predictive value; Trop T, troponin T; H-FABP, heart-type fatty acid-binding protein.
The average time when each marker was determined from the onset of ACS was 4 h and 40min.
Table 5 Positive test rate of D-dimer and cardiac biochemical markers in patients with ACS.
Time from onset
Within 2 h (n = 19) 2—6h (n = 20) 6—24 h (n = 16)
D-dimer (≥0.75) 58%* 60% 81%
Trop T 21% 45% 65%
H-FABP 47% 90% 88%
Trop T, troponin T; H-FABP, heart-type fatty acid-binding protein
* p < 0.05 vs. Trop T.
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tatistical signiﬁcance compared with troponin
.
iscussion
-dimer for diagnosis of acute
ardiovascular disease
ymptoms, including chest pain, dyspnea, back
ain, from which ACVD is suspected or not ruled
ut, are frequent symptoms of emergent patients.
CVD, including acute aoritc dissection, pulmonary
hromboembolism, and ACS, are sometimes fatal.
herefore the screening and the speedy diagnosis
f ACVD are important in the emergency setting.
D-dimer is the end product of cross-linked
brin breakdown and indicates active thrombus
ormation and lysis. Previous studies showed the
tility of D-dimer measurement for the screening
f acute aortic dissection, pulmonary throm-
oembolism, and myocardial infarction [1—6,9].
owever, the utility of rapid D-dimer measure-
ent for the screening of ACVD as a group
f diseases in emergent patients has not been
eported. Therefore, we enrolled all the patients,
ho visited the emergency room with symp-
oms suggestive of ACVD or in whom ACVD could
ot be ruled out, and evaluated the utility of
apid D-dimer measurement for the screening of
CVD.
When the cut-off level of D-dimer was set at
ow (0.5g/ml), the sensitivity and negative pre-
ictive value were high (92% and 90%, respectively),
ut speciﬁcity and positive predictive value were
ow (27% and 32%, respectively). When the cut-
ff level of D-dimer was set at high (5.0g/ml),
he speciﬁcity and positive predictive value were
igh (99% and 93%, respectively), but sensitivity
as low (19%). Therefore, we attempted to ﬁnd
well-balanced cut-off level of D-dimer for the
creening of ACVD using the ROC curve. As a result,
he level of D-dimer at 0.75g/ml was selected.
hen the patients were classiﬁed according to
hese three cut-off levels of D-dimer, rapid D-dimer
easurement proved useful for the screening and
iscrimination of ACVD in patients with chest symp-
oms. And in the patients with ACVD, well-balanced
ut-off point to discriminate the patients with ACS
nd those with large vessel disease was D-dimer
evel of 5.0g/ml. That is, if the value of D-dimer
s lower than 0.5g/ml, the chance of ACVD is
ow. When the value of D-dimer is higher than
.75g/ml, ACVD could not be ruled out and partic-
larly ACS was suspected, so careful discrimination
s necessary. On the other hand, when the value ofscular disease 339
D-dimer is higher than 5.0g/ml, ACVD, especially
large vessel disease, is strongly suspected and strict
management is necessary.
D-dimer for diagnosis of acute coronary
syndrome
D-dimer has been established as a useful aid in
the diagnosis of deep vein thrombosis, pulmonary
thromboembolism, and acute aortic dissection
[1—6,17,18]. Few data have been reported on the
values of D-dimer in the diagnosis of ACS, and those
data are still controversial [7—10]. The present
study showed the usefulness of D-dimer for the
diagnosis of ACS. Cardiac biochemical markers,
such as troponin T or H-FABP, are highly selective
for myocardial injury, but not sensitive enough in
the very early phase after the onset of ACS (within
a couple of hours after the onset) [14—16]. It was
reported that coronary artery thrombus formation
is the very early pathophysiological change in ACS
[19,20]. Since D-dimer level represents thrombus
formation, D-dimer level would be expected to rise
earlier than cardiac biochemical markers in acute
coronary syndrome [21]. In our study, compared
with troponin T, D-dimer showed higher positive
test rate in the patients with ACS in the very early
phase (within 2 h) after the onset of symptoms.
The positive test rate of D-dimer and H-FABP in
this phase were similar, however, D-dimer would
be more useful than H-FABP, since rapid D-dimer
assay was a quantitative test whereas available
rapid test of H-FABP was qualitative. That is, as
was mentioned above, by using several cut-off lev-
els of D-dimer, ACS could be discriminated from not
only non-ACVD, but also from large vessel disease.
Therefore, D-dimer could be a useful screening
marker of ACVD, including not only pulmonary
thromboembolism and acute aortic dissection, but
also ACS.
Limitations of screening of acute
cardiovascular disease by D-dimer
D-dimer showed high sensitivity for the diagnosis of
ACVD, however, a remaining problem was that the
ratio of false positive was high. It was reported that
D-dimer concentration was increased in patients
with not only ACVD and also in patients with infec-
tion, malignancy, renal disease, liver disease, or old
age [22]. Therefore, it is necessary to take into con-
sideration any of these underlying conditions when
evaluating the utility of D-dimer. However, in this
study, the correlation between age and ACVD was
not observed by the regression analysis.
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Conclusion
Rapid D-dimer measurement in serum appears to be
useful for the screening of ACVD in the emergency
setting.
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